Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.18% | 79.42% | 68.93% | 65.18% | 68.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.31% | 75.85% | 4.37% | -11.89% | -29.80% |
| Operating Income | -44.31% | -75.85% | -4.37% | 11.89% | 29.80% |
| Income Before Tax | -37.77% | -94.61% | -6.12% | 13.47% | 34.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.77% | -94.61% | -6.12% | 13.47% | 34.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -37.77% | -94.61% | -6.12% | 13.18% | 32.61% |
| EBIT | -44.31% | -75.85% | -4.37% | 11.89% | 29.80% |
| EBITDA | -133.40% | -515.21% | -- | -- | -- |
| EPS Basic | -15.14% | -45.51% | 56.02% | 87.51% | 98.88% |
| Normalized Basic EPS | 3.09% | -12.81% | 52.95% | 79.62% | 98.46% |
| EPS Diluted | -15.14% | -45.51% | 56.02% | 87.51% | 98.88% |
| Normalized Diluted EPS | 3.09% | -12.81% | 52.95% | 79.62% | 98.46% |
| Average Basic Shares Outstanding | 45.47% | 69.40% | 97.66% | 127.76% | 201.02% |
| Average Diluted Shares Outstanding | 45.47% | 69.40% | 97.66% | 127.76% | 201.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |